Increased reporting of cerebrovascular accidents with use of risankizumab observed in the Food and Drug Administration Adverse Events Reporting System (FAERS)

11 Citationer (Scopus)
OriginalsprogEngelsk
TidsskriftBritish Journal of Dermatology
Vol/bind188
Udgave nummer6
Sider (fra-til)793-794
Antal sider2
ISSN0007-0963
DOI
StatusUdgivet - 24 maj 2023

Citationsformater